Bile Duct Cancer,BTC
Conditions
Interventions
Control Group:Traditional regimens
Experimental Group:Choosing chemotherapy or targeted therapy according to Mini PDX drug sensitivity test
Sponsors
Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. The pathological diagnosis is bile duct cancer, including gallbladder carcinoma, cholangiocarcinoma and so on; 2. The predictive survival time longer than 3 months; 3. Approved by in person of by client, and volunteering to offer relevant personal information, tissue specimen etc; 4. PKS score more than 60 and chemotherapy and targeted therapy can be tolerated by the patient through comprehensive evaluation.
Exclusion criteria
Exclusion criteria: 1. Unable or refusing to the specimens, including tumor tissue, malignant hydrothorax and ascites or circulating tumor cells; 2. Refusing to accept relevant therapies or follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overal Survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression-free survival; | — |
Countries
China
Contacts
Public ContactChen Wei
Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine
Outcome results
None listed